GlassScriptPhysician profile
Sajid MD Malik
NPI 1235227349
$1,917.43
in general payments reported to CMS, 2019-2025
14 companies · $320 in 2025
The $320 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $593 · 2020: $178 · 2021: $13.27 · 2022: $20.02 · 2023: $244 · 2024: $549 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,113.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $414.12 | 2019-2025 | Clareon, Argos |
| Bausch & Lomb Americas INC. | $414.05 | 2023-2025 | Envista Mx60 Iol, Envista Aspire Iol, Doctors Allergy Formula |
| Johnson & Johnson Surgical Vision, INC. | $390.96 | 2019-2025 | Tecnis Iol, Tecnis Simplicity, Amo Phaco Needle |
| Sight Sciences, INC. | $268.03 | 2019-2022 | |
| New World Medical,INC. | $169.25 | 2019-2025 | Streamline, Via360, Ahmed Glaucoma Valve |
| Amgen INC. | $89.70 | 2024-2025 | Tepezza |
| Aerie Pharmaceuticals, INC. | $36.42 | 2019 | |
| Allergan, INC. | $29.27 | 2020-2021 | |
| Astellas Pharma US INC | $23.62 | 2024 | Izervay |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $18.73 | 2024 | Xdemvy |
| Oyster Point Pharma, INC. | $15.45 | 2025 | Tyrvaya |
| Dompe US, INC. | $15.14 | 2019 | |
| Abbvie INC. | $13.29 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sajid Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.